Women’s health is expanding through hormone-focused, lifecycle nutrition. At Vitafoods, Nexira launches BloomEase™, a science-backed solution combining botanicals and marine magnesium to support premenstrual syndrome and improve women’s comfort and well-being.
Women’s health is emerging as one of the most strategic and fast-evolving segments in the nutraceutical industry. Once limited to targeted or niche applications, it is now expanding into a comprehensive, lifecycle-based approach that integrates hormonal health, prevention, and long-term well-being. This shift reflects a broader transformation in healthcare, where prevention is no longer episodic but continuous, adapting to hormonal cycles, life stages, and evolving physiological needs.
The market fundamentals clearly support this momentum. The global women’s health and beauty supplement market, valued at $57.4 billion in 2024, is projected to reach $77.4 billion by 2030, growing at a CAGR of 5.25% (Grand View Research). Beyond size, what is particularly striking is how the category is being structurally reshaped by hormonal health. According to Innova Market Insights, 29% of women are in their natural hormonal cycle, while 37% are in pre-, peri-, or post-menopause. In other words, nearly two-thirds of women globally are directly impacted by hormonal fluctuations, making hormones a central framework for innovation.
Hormonal health is no longer confined to fertility-related topics. It is now closely associated with a wide range of health outcomes, including mood, cognition, metabolism, skin health, sleep quality, and overall vitality. As awareness increases, women are seeking holistic, multifunctional solutions that go beyond symptom management to support well-being across time. Clean-label, natural, and stage-specific products are becoming the norm, with consumers expecting formulations that address multiple concerns simultaneously, such as emotional balance, digestive comfort, joint health, or metabolic support.
This evolution is structuring the market around key life stages. For women aged 20 to 45, the focus is on performance, beauty, and emotional balance, with growing interest in personalized nutrition and preventive care. Purchase drivers include improving physical appearance (24%), hormone balance (18%), and metabolism support (18%) (Innova Health & Nutrition Survey 2025). This segment is fueling demand for solutions targeting premenstrual syndrome (PMS) and overall cycle regulation.
For women aged 45 and above, priorities shift toward healthy aging, longevity, and managing hormonal transitions such as menopause. This stage is increasingly approached holistically, with strong interest in aging well (27%), joint health (23%), and inflammation reduction (16%). Menopause, once under-addressed, is now a core innovation platform, extending beyond traditional symptoms to include cognitive function, metabolic balance, and long-term vitality.
Within this dynamic landscape, Nexira is expanding its Women Health Collection with the launch of BloomEase™, a new solution specifically designed to support women experiencing PMS. BloomEase™ combines Achillea millefolium flower extract, traditionally used for menstrual comfort, with marine-sourced magnesium to address both physical discomfort and mood-related symptoms. Its efficacy is supported by a real-life human study conducted in 167 women, demonstrating a faster and greater reduction in menstrual pain, alongside improved quality of life and reduced PMS severity across cycles.
With BloomEase™, Nexira reinforces its commitment to science-backed, natural solutions that align with the growing demand for targeted, lifecycle-based women’s health innovation. Discover BloomEase™ at Vitafoods Europe, booth #3C70 and join our Pitch & Coffee session on Wednesday, May 6 at 11:00am to learn more and connect with our team.